2024-10-28T10:34:41-05:00 2022-12-31 202253063 TANNER LLC 36 S STATE STREET SUITE 600 SALT LAKE CITY UT 84111 990 2022-01-01 870687610 BATEMAN HORNE CENTER OF EXCELLENCE BATE 8018792789 24 SOUTH 1100 EAST STE 201 SALT LAKE CITY UT 84102 ROBERT ENCE EXECUTIVE DIRECTOR 8018792789 2024-10-25 1 0 MARC A METCALF P00170461 8015327444 2024-10-25 2022 2024-10-15 13:58:12Z ROBERT ENCE 24 SOUTH 1100 EAST STE 201 SALT LAKE CITY UT 84102 2103771 0 X WWW.BATEMANHORNECENTER.ORG X 2001 UT TO RAISE AWARENESS OF CHRONIC FATIGUE SYNDROME AND FIBROMYALGIA AND PROVIDE INFORMATION, CLINICAL CARE, RESEARCH PROJECTS, AND EDUCATIONAL PROGRAMS FOR PATIENTS AND PROFESSIONALS. 10 10 24 12 0 0 923866 1143536 1133015 781043 17696 -78504 23868 7219 2098445 1853294 0 0 0 0 1488422 1580074 0 0 31000 610961 516889 2099383 2096963 -938 -243669 646829 962397 390779 960738 256050 1659 THE PRIMARY EXEMPT PURPOSE OF THE BATEMAN HORNE CENTER OF EXCELLENCE IS TO RAISE AWARENESS OF CHRONIC FATIGUE SYNDROME AND FIBROMYALGIA AND PROVIDE PATIENTS AND PROFESSIONALS WITH INFORMATION, CLINICAL CARE, AND INTEGRATED RESEARCH PROJECTS. 0 0 910582 535434 RESEARCH: BHC CONDUCTS RESEARCH TO DEFINE CORE SIGNS, SYMPTOMS, AND DECREMENTS IN SPECIFIC FUNCTIONING. BHC CONTINUES TO DRIVE BIOMARKER DISCOVERY BY SHARING BIOLOGICAL SAMPLES AND CLINICAL INFORMATION WITH THE BRIGHTEST SCIENTISTS AROUND THE WORLD. 961063 252828 CLINICAL CARE: BHC MAINTAINS AN EXPERT CONSULTATION AND CLINICAL CARE CENTER TO PROVIDE PATIENTS AN IN-DEPTH DIFFERENTIAL DIAGNOSIS, DEVELOP A HEALTH MANAGEMENT PLAN, AND ESTABLISH WELL-DEFINED PARTICIPANTS FOR TARGETED CLINICAL TRIALS FOR ME/CFS, FM, LONG COVID, AND RELATED COMORBIDITIES. 112659 EDUCATION: BHC CREATES, AGGREGATES, AND DELIVERS EDUCATIONAL RESOURCES AND PROGRAMMING FOR PATIENTS AND CARE PARTNERS FOR SELF-MANAGEMENT AND EMPOWERMENT. BHC PROVIDES INFORMED AND COMPREHENSIVE EDUCATIONAL RESOURCES AND TRAINING FOR HEALTHCARE PROVIDERS TO IMPROVE ACCESS TO QUALITY CARE. EARLY AND INFORMED INTERVENTION OF ME/CFS, FM, LONG COVID AND RELATED COMORBIDITIES, CAN SIGNIFICANTLY IMPROVE PATIENT OUTCOMES AND DISEASE MANAGEMENT. 1984304 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 0 24 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 10 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 1 1 0 UT X ROB ENCE 8015560458 24 S 1100 E 205 SALT LAKE CITY UT 84102 ALLEN PEGGY DIRECTOR 1.00 X 0 0 0 DONNELLY SHARON DIRECTOR, BOARD SECRETARY 4.00 X X 0 0 0 HANSEN LUKE DIRECTOR 1.00 X 0 0 0 KALY TED DIRECTOR, BOARD VICE CHAIR 2.00 X X 0 0 0 LIGHT ALAN DIRECTOR 1.00 X 0 0 0 MASON DAVE DIRECTOR 1.00 X 0 0 0 MILNE LINDA DIRECTOR 1.00 X 0 0 0 ROMINGER MARY SUE DIRECTOR, BOARD CHAIR 4.00 X X 0 0 0 SORENSEN VELDON DIRECTOR, BOARD TREASURER 3.00 X X 0 0 0 TURNER JESSICA DIRECTOR 1.00 X 0 0 0 ENCE ROB EXECUTIVE DIRECTOR 40.00 X 0 0 0 YELLMAN BRAYDEN MEDICAL PROVIDER MD 40.00 X 160000 0 0 BATEMAN LUCINDA MEDICAL DIRECTOR, MD 40.00 X 121500 0 0 281500 0 0 2 0 1 0 0 299168 844368 8500 1143536 RESEARCH INCOME 541700 535434 535434 PATIENT INCOME 621110 245609 245609 781043 91 91 171882 250477 -78595 -78595 -78595 OTHER INCOME 900099 7219 7219 7219 1853294 788262 0 -78504 281500 267424 8744 5332 1038408 986485 32255 19668 16741 15907 834 103941 98744 5197 139484 132510 6974 585 556 29 6043 5741 302 105278 100014 5264 189917 180421 9496 505 480 25 2342 2108 234 1651 1486 165 9706 9221 485 33332 29999 3333 LAB & RESEARCH EXPENSES 124079 111671 6408 6000 BAD DEBT 18199 18199 EQUIPMENT 12237 11625 612 BUSINESS REGISTRATION 6751 6076 675 6264 5637 627 2096963 1984304 81659 31000 224067 158054 144409 203891 10780 10580 220958 202664 18020 18294 249553 202475 0 369103 646829 962397 223394 168833 101707 112015 65678 260653 0 419237 390779 960738 X 256050 1659 256050 1659 646829 962397 -243669 -10722 0 X 0 0 0 X 502104 573656 744736 687566 1143536 3651598 881339 1046821 795692 1133015 781043 4637910 1383443 1620477 1540428 1820581 1924579 8289508 124346 177364 232500 316510 384211 1234931 0 124346 177364 232500 316510 384211 1234931 7054577 2116 466 180 714 91 3567 2116 466 180 714 91 3567 1385559 1620943 1540608 1821295 1924670 8293075 0.85070 0.85710 0.00040 0.00070 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 108318 107512 806 112640 95152 17488 18294 RIGHT OF USE ASSETS 369103 369103 LEASE LIABILITY 419237 419237 X 0 0 0 0 0 0 0 0 0 YELLMAN BRAYDEN MEDICAL PROVIDER MD 160000 0 0 0 0 0 0 0 0 0 160000 0 0 0 LUCINDA BATEMAN MEDICAL DIRECTOR CASH FOR OPERATIONS X 127986 147653 0 1 0 ROB ENCE EXECUTIVE DIRECTOR CASH FOR OPERATIONS X 33694 113000 0 1 0 260653 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS REVIEWED BY THE ACCOUNTING MANAGER, THE EXECUTIVE DIRECTOR, AND THE CHAIR OF THE BOARD OF DIRECTORS BEFORE IT WAS FILED. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION FOR THE EXECUTIVE DIRECTOR IS ESTABLISHED BY THE BOARD OF DIRECTORS BASED ON THE EXECUTIVE DIRECTOR'S EXPERIENCE AND LOCAL COMPENSATION COMPARABLES. THE EXECUTIVE DIRECTOR SETS THE COMPENSATION LEVELS AND PROCESSES FOR THE REST OF THE STAFF BASED ON THE INDIVIDUAL'S EXPERIENCE AND LOCAL COMPENSATION COMPARABLES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS FINANCIAL INFORMATION AVAILABLE TO THE PUBLIC UPON REQUEST.